Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation
- 14 March 2000
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 54 (5) , 1193-1195
- https://doi.org/10.1212/wnl.54.5.1193
Abstract
Article abstract Although nigrostriatal dopaminergic dysfunction has been suggested in early onset primary torsion dystonia (PTD) with the DYT1 mutation, the actual status of brain dopamine (DA) is unknown. In a DYT1 mutation–positive autopsy patient with PTD, we found that nigral cellularity was normal and that subregional striatal DA levels were within the control range, except for those in the rostral portions of the putamen and caudate nucleus (50% to 54% of control means). Our data suggest that the DYT1 mutation is not associated with significant damage to the nigrostriatal DA system, in keeping with the absence of parkinsonism and levodopa response in this disorder.Keywords
This publication has 8 references indexed in Scilit:
- Dopa-responsive dystonia: Recent advances and remaining issues to be addressedMovement Disorders, 1999
- Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystoniaNeurology, 1999
- Changes and new features in NeurologyNeurology, 1998
- Expression of the early‐onset torsion dystonia gene (DYT1) in human brainAnnals of Neurology, 1998
- The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding proteinNature Genetics, 1997
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- Brain Neurotransmitters in DystoniaNew England Journal of Medicine, 1987
- Brain Neurotransmitters in Dystonia Musculorum DeformansNew England Journal of Medicine, 1986